wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38992409-28F4E81E-1114-4CBB-8996-2E9B7816A261
Q38992409-28F4E81E-1114-4CBB-8996-2E9B7816A261
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38992409-28F4E81E-1114-4CBB-8996-2E9B7816A261
Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study.
P2860
Q38992409-28F4E81E-1114-4CBB-8996-2E9B7816A261
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38992409-28F4E81E-1114-4CBB-8996-2E9B7816A261
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
27ad9635b33c15a44c650cb715ee9dc439d9d186
P2860
The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid.